Inflammatory Dilated Cardiomyopathy clinical trials

Explore recruiting inflammatory dilated cardiomyopathy clinical trials.

Also recruiting in Europe

Inflammatory Dilated Cardiomyopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Deciphering IL-1 mediated inflammation for the targeted treatment of dilated cardiomyopathy.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Inflammatory Dilated Cardiomyopathy trials by city

Inflammatory Dilated Cardiomyopathy in Toronto Inflammatory Dilated Cardiomyopathy in Vancouver Inflammatory Dilated Cardiomyopathy in Montreal Inflammatory Dilated Cardiomyopathy in Calgary Inflammatory Dilated Cardiomyopathy in Edmonton Inflammatory Dilated Cardiomyopathy in Ottawa Inflammatory Dilated Cardiomyopathy in Winnipeg Inflammatory Dilated Cardiomyopathy in Quebec City Inflammatory Dilated Cardiomyopathy in Hamilton Inflammatory Dilated Cardiomyopathy in Kitchener Inflammatory Dilated Cardiomyopathy in London Inflammatory Dilated Cardiomyopathy in Halifax Inflammatory Dilated Cardiomyopathy in New York Inflammatory Dilated Cardiomyopathy in Los Angeles Inflammatory Dilated Cardiomyopathy in Chicago Inflammatory Dilated Cardiomyopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease